Saturday, October 23, 2021
Home Search

FOPE - search results

If you're not happy with the results, please do another search
FOPE

Section 1(3), 2, 3(c) & 3(h) of D&C Act non-implementable: FOPE

The Federation of Pharmaceutical Entrepreneurs (FOPE) has now identified certain provisions of Drugs & Cosmetics Act & Rules as redundant.
FOPE

FOPE urges govt to change title of D&C Act to MMDC Act

The Federation of Pharmaceutical Entrepreneurs (FOPE) is of the view that there is a need for a contemporary identity for the existing...
FOPE

Webinar by FOPE on Cosmetic Rules 2020

A webinar on Cosmetic Rules 2020 organised by FOPE on the initiative taken by Bodh Raj Sikri, Chairman FOPE and Vinod Kalani...
Medicines

Incentives not enough, API industry seeks more: FOPE

Even as the government hopes to see a tremendous response for its production linked incentive (PLI) scheme for greenfield bulk drug manufacturing projects,...
FDA Haryanavideo

Video: Thank you FDA Haryana-BR Sikri, FOPE

Video: Thank you FDA Haryana https://www.youtube.com/watch?v=Bed9DXQLXMY Also watch: Video: How tablets are manufactured
FDA Haryana

Thank you FDA Haryana: B R Sikri FOPE

For me all Regulators  are loveable and respectable but recent contribution of Haryana regulatory team particularly during COVID 19 is matter of...
Medicine Factory

Fermentation products mfg may need more push than PLI scheme: Experts

Even as the Central government has come out with significant measures to support production of key starting materials (KSMs), active pharmaceutical ingredients...
NPPA Price of drugs

NPPA seeks details for 29 formulations from Drug Mfrs to fix ceiling prices

The National Pharmaceutical Pricing Authority (NPPA) has asked drug manufacturers and marketers to furnish the information relating to price to retailer (PTR)...
Govt DoP

Pharma Ind appeals to DoP to keep new PLI scheme open for all APIs

The drug industry has appealed to the Department of Pharmaceuticals (DoP) to allow all active pharmaceutical ingredients (APIs) / intermediates under category...
Medicine

Prices of essential medicines to go up

Prices of essential medicines including painkillers, anti-infectives, cardiac and antibiotics could go up marginally from April, with the government allowing drug makers an increase in...
NPPA Price of drugs

NPPA to Pharma Industry to adopt IPDMS

The National Pharmaceutical Pricing Authority (NPPA) has asked all the industry associations to encourage their member companies to start using the online...
Strike Meeting

Pharma Industry welcomes PLI Scheme, awaits implementation details

Pharma Industry welcomes PLI Scheme, awaits implementation details The Union Cabinet’s decision to approve the Production Linked Incentive (PLI) 2.0...
Govt India

More Pharma firms for PLI scheme to boost bulk drug output: Govt

The government plans to select more pharmaceutical firms for its production-linked incentive (PLI) scheme for 37 bulk drugs by the end of...
X Ray Medical Hospital Doctor

Medical x-ray machines: DoP to promote domestic manufacturing

The Department of Pharmaceuticals (DoP) has prepared a phased manufacturing programme (PMP) in consultation with department of revenue (DoR) to promote domestic...
DCGI CDSCOvideo

Video: Press Conference by DCGI on Vaccine

Video: Press Conference by DCGI on Vaccine https://www.youtube.com/embed/oINgRbrf5hA Dr. VG Somani, Drugs Controller General of India
NK Ahoojavideo

Video: Interview on Pharma: NK Ahooja SDC Haryana

Video: Interview on Pharma: NK Ahooja SDC Haryana https://www.youtube.com/watch?v=hQzUce2M-nY&feature=youtu.be Also watch:
Joe Biden

The Biden effect on Indian Pharma Cos

The Biden effect on Indian Pharma Companies We expect there to be an even stronger focus on generics...
Meeting Committee FDA

Committee to identify investment opportunities, bottlenecks in pharma industry: DoP

Committee to identify investment opportunities, bottlenecks in pharma industry The Department of Pharmaceuticals (DoP) has created a six-member expert...
DoP issues letter to Pharma Associations to ensure adherence to UCPMP

DoP issues letter to Pharma Associations to ensure adherence to UCPMP

The Department of Pharmaceutical (DoP) has issued a letter to the pharma industry’s key associations, namely; IDMA, BDMA, IPA, OPPI and FOPE...
Medicine

Selected patented drugs should be included in NLEM

By - BR Sikri, Chairman FOPE and VP BDMA An intense debate is going...
FDA Haryana

आत्म निर्भर भारत – FDA हरियाणा

आत्म निर्भर भारत - FDA हरियाणा आत्म निर्भर भारत समय की मांग है और हरियाणा के परिपेक्ष्य में कोरोना...
Meeting Committee FDA

Discussion on regulatory roadmap for pharma industry

There is a need for clear cut research and development policies in the Indian regulatory system, said Eswara Reddy, Joint Drug Controller...
Medicine Capsule

Big opportunity for Indian pharma exporters

The oncology drug makers in India have a tremendous opportunity in Mexico which has witnessed one third of deaths due to cancer...
Medicine

Rajasthan pharma sought support from Govt to set up API parks

With an aim to attract pharma investors to Rajasthan and optimise Central Government’s bulk drug park schemes, the Rajasthan Pharmaceutical Manufacturers Association...

Latest posts

NPPA releases draft of retail price calculation for 5 formulations

The National Pharmaceutical Pricing Authority (NPPA) has released draft version of proposed retail price calculation for five formulations, including a combination of...

Authors

51 POSTS0 COMMENTS
30 POSTS0 COMMENTS
16 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS